We offer a full portfolio of cutting-edge fluid biomarker testing for Alzheimer's disease and related dementias. Get the answers you need to guide diagnosis and care at every point in your patient's journey with dementia. Learn more. https://bit.ly/4eS1GZy
About us
As the global reference laboratory for Mayo Clinic, Mayo Clinic Laboratories will help you advance patient care, strengthen your practice, and broaden access to specialized testing. Through our partnerships with clinicians at Mayo Clinic and health care providers around the world, we are able to offer the most sophisticated test catalog in the world. It is because of these daily collaborations that our subspecialized laboratories continue to be a critical component to patient care at Mayo Clinic. - 4.5 million patients worldwide - 3,000 plus tests and pathology services - 24 million tests performed annually - 4,500 physicians and scientists at Mayo Clinic - 90 plus subspecialty pathologists - 560 peer-reviewed articles published annually
- Website
-
http://www.mayocliniclabs.com
External link for Mayo Clinic Laboratories
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Rochester, Minnesota
- Type
- Privately Held
- Founded
- 1971
Locations
-
Primary
Get directions
3050 Superior Dr NW
Rochester, Minnesota 55901, US
Employees at Mayo Clinic Laboratories
Updates
-
Most healthcare organizations say they prioritize innovation, but without a unified framework, good intentions rarely translate into meaningful progress. William Morice II, MD, PhD, president and CEO of Mayo Clinic Laboratories, breaks down exactly what separates innovation strategies that deliver results from those that quietly stall. Read more.
-
How has digital innovation changed the way we think about diagnostics? Chris Garcia, M.D., chief digital innovation officer at Mayo Clinic Laboratories, discusses how digital technology, AI, and advanced analytics continue to reshape healthcare.
-
Mayo Clinic Laboratories neurologists and testing scientists pioneered patient-centric multiple sclerosis testing, introducing a kappa free light chain profile that reflexes to oligoclonal banding in 2020. The approach, which aligns with 2024 updates to the McDonald Criteria, provides fast answers and empowers physicians to confidently diagnose and treat patients. Learn more. https://bit.ly/4sAOED5
-
-
LiquidHALLMARK® liquid biopsy testing provides detailed information on a patient’s cancer by sequencing both circulating tumor DNA and circulating tumor RNA, which may offer advantages over other commercially available liquid biopsy options. https://bit.ly/4rlGjDH
-
-
At Mayo Clinic Laboratories, we take bold ideas and turn them into practical solutions that redefine diagnostics and elevate patient care. By uniting research with real-world application and fostering collaboration across disciplines, we accelerate innovation from the lab to the clinic, ensuring every advancement delivers measurable impact for those who need it most.
-
The emphasis of AI in the lab is on strengthening daily workflows while keeping experts firmly in control. At Mayo Clinic Laboratories, teams use AI to organize information, reduce repetitive steps, and improve consistency. Learn more in this "Eye on Innovation." https://bit.ly/4uUaFPB
-